David H. Donabedian
Biopharmaceutical
Axial Biotherapeutics
United States of America
Biography
David H. Donabedian, Ph.D., will fill in as Chief Executive Officer of Axial and will likewise serve on its Board. Dr. Donabedian is an expert business advancement and procedure official with broad authority encounter. Dr. Donabedian has a reputation of building organizations, most as of late as a Venture Partner at Longwood Fund.
Research Interest
Adult Tissue Stem Cell Production, Mouse | Rat | Human Tissue Cells,Identification of Adult Stem Cells, Drug Development & Regenerative Medicine, Biomarker Development, Adult Stem Cell Engineering
